Mustali Ariwala

• Expanded national market coverage by establishing strategic distributor partnerships that improved commercial reach and
supply efficiency in a structurally constrained market.
• Achieved 80% of annual revenue target in Year 1 and 73% in Year 2 by steering country-level commercial strategy with disciplined
execution in a volatile, FX-constrained environment.
• Delivered 7% year-on-year growth by protecting demand pipelines, optimising channel effectiveness, and adapting quickly to
currency depreciation and macroeconomic disruption.
• Improved gross margins by 15% across priority portfolios by refining pricing strategy, optimising product mix, and controlling
commercial costs.
• Accelerated portfolio scale-up by launching 16 product lines and 20 SKUs through market segmentation, demand forecasting,
and phased commercial rollout.
• Strengthened execution discipline by building a performance-driven commercial team supported by territory structure,
productivity metrics, and governance controls.
• Protected profitability under market pressure by owning full P&L management, including budgeting, forecasting, pricing
decisions, and cost structures.

• Delivered 50% year-on-year revenue growth in 2021 by executing a five-year growth roadmap built on portfolio prioritization
and market expansion.
• Exceeded profitability objectives with 22% gross margin versus a 15% plan by enforcing pricing discipline, cost control, and
portfolio mix optimization.
• Improved cash-flow predictability and working-capital efficiency by strengthening distributor governance and credit-risk
frameworks.
• Built scalable commercial control by establishing robust reporting systems, performance governance, and operational oversight
across group entities.
• Improved decision quality by integrating budgeting, forecasting, and P&L accountability into enterprise commercial
management.
• Strengthened long-range business direction by developing and executing strategic plans aligned to multi-market expansion
goals.
• Increased execution reliability by coordinating finance, supply chain, operations, and regulatory teams around shared
commercial priorities.

• Generated more than 74% year-on-year growth by driving disciplined commercial execution, volume expansion, and operating
leverage across diversified business verticals.
• Turned around underperforming business units by restructuring portfolios, recalibrating pricing models, and redesigning
channel architecture.
• Created incremental revenue streams by establishing and scaling raw material and packaging businesses in high-potential
market segments.
• Strengthened sourcing reliability and supply continuity by expanding long-term supplier and distributor partnerships across
international markets.
• Improved regional execution capability by building cross-border teams that combined local market knowledge with centralized
commercial governance.
• Accelerated multi-country growth by leading business operations across Africa with direct accountability for revenue, margin,
and operating discipline.
• Protected profitability by owning end-to-end P&L decisions covering pricing, cost structures

• Expanded group-level commercial reach by leading market growth strategy, portfolio development, and sales execution across
Nigeria.
• Strengthened route-to-market effectiveness by improving customer engagement models and distribution scale-up initiatives.
• Improved execution continuity by coordinating closely with supply chain, regulatory, and external partners.

• Stabilised and grew Nigerias profit-centre operations by leading petrochemical and polymer trading with full P&L accountability.
• Expanded BOPP and PET business by driving sales, distribution, imported supply chains, and strategic customer development.
• Sustained profitability in a complex market by combining disciplined execution with focused new business development.
• Earned the Group Presidents Award by delivering business innovation and performance impact.

• Established market presence across Nigeria and West Africa by leading entry strategy, regulatory approvals, and distributor
development.
• Scaled operations across APIs, formulations, and healthcare products by building commercial models and channel strategies
around regional demand.
• Strengthened cross-border growth readiness by creating compliant operating structures for sustainable expansion.

• Delivered up to 44% growth within two years by expanding territories, scaling portfolios, and launching multiple products.
• Built a new Strategic Marketing and Specialty Business Unit by identifying growth white spaces and commercializing targeted
offerings.
• Managed a USD 2M portfolio and led a 60-member team to improve productivity, collaboration, and execution effectiveness.
• Earned the Directors Performance and Excellence Award by driving strategic partnerships and commercial efficiency.

• Revived failing brands by repositioning portfolios, expanding markets, and activating demand across INR 300M business.
• Improved launch outcomes by leading cross-functional coordination across sales, marketing, and supply interfaces.

• Accelerated portfolio growth by leading product management for a INR 500M business with strong launch execution.
• Generated INR 10M within eight months for an international brand by driving focused commercialization and market uptake.
• Expanded global commercial exposure by representing the company at an international marketing forum in Germany.

• Delivered INR 40M revenue within the first year by helping establish the Human Vaccines division from inception.
• Built nationwide distribution and service capability by restructuring sales operations; aligning field execution with product
adoption goals.
• Earned the MDs Letter of Appreciation by coordinating effectively with R&D, manufacturing, and commercial teams.

• Supported portfolio growth by contributing to product commercialization, field execution, and sales enablement.

• Built foundational expertise in portfolio management, product launches, and commercial execution through progressive
marketing leadership responsibilities.